e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Biomarkers and outcomes of community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The ability of pro adrenomedullin to predict severe sepsis in patients with comunity-acquired pneumonia
A. Uranga, P. P. España, A. Capelastegui, I. Gorordo, R. Diez, A. Bilbao, C. Mar, E. Bereciartua, E. Bereciartua (Galdakao, Sondika, Spain)
Source:
Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Session:
Biomarkers and outcomes of community-acquired pneumonia
Session type:
Poster Discussion
Number:
1467
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Uranga, P. P. España, A. Capelastegui, I. Gorordo, R. Diez, A. Bilbao, C. Mar, E. Bereciartua, E. Bereciartua (Galdakao, Sondika, Spain). The ability of pro adrenomedullin to predict severe sepsis in patients with comunity-acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 1467
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
How I manage severe sepsis
Source: Annual Congress 2010 - How I manage severe sepsis
Year: 2010
The influence of inadequate starting empirical antimicrobial therapy of septic pneumonia on outcomes at patients with angiogenic sepsis
Source: Eur Respir J 2004; 24: Suppl. 48, 549s
Year: 2004
The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Compliance with severe sepsis bundles and its effect on outcomes of severe pneumonia and septic shock in a Chinese hospital
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
The interconnection of severe pneumonia and sepsis
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004
An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
The role of endothelin-1 in hospitalized patients with community-acquired pneumonia.
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Local and systemic cytokine profiles in patients with non-severe and severe community-acquired pneumonia
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Adrenal insufficiency and relative eosinophilia in critically ill patients with septic shock due to ventilator-associated pneumonia (VAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009
Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
The role of ghrelin in critically-ill patients with sepsis
Source: International Congress 2017 – Sepsis, infections, ARDS and beyond
Year: 2017
ARDS and sepsis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=253
Year: 2005
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Source: Eur Respir J 2002; 20: 990-995
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept